Center for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA.
J Alzheimers Dis. 2011;27(3):483-90. doi: 10.3233/JAD-2011-110866.
Biomarker studies demonstrate inheritance of glucose hypometabolism and increased amyloid-β deposition in adult offspring of mothers, but not fathers, affected by late-onset Alzheimer's disease (LOAD). The underlying genetic mechanisms are unknown. We investigated whether cognitively normal (NL) individuals with a maternal history of LOAD (MH) have reduced platelet mitochondrial cytochrome oxidase activity (COX, electron transport chain complex IV) compared to those with paternal (PH) or negative family history (NH). Thirty-six consecutive NL individuals (age 55 ± 15 y, range 27-71 y, 56% female, CDR = 0, MMSE ≥28, 28% APOE-4 carriers), including 12 NH, 12 PH, and 12 MH, received a blood draw to measure platelet mitochondrial COX activity. Citrate synthase activity (CS) was measured as a reference. Groups were comparable for clinical and neuropsychological measures. We found that after correcting for CS, COX activity was reduced by 29% in MH compared to NH, and by 30% in MH compared to PH (p ≤ 0.006). Results remained significant controlling for age, gender, education, and APOE. No differences were found between PH and NH. COX measures discriminated MH from the other groups with accuracy ≥75%, and relative risk ≥3 (p ≤ 0.005). Among NL with LOAD-parents, only those with MH showed reduced COX activity in platelet mitochondria compared to PH and NH. The association between maternal history of LOAD and systemic COX reductions suggests transmission via mitochondrial DNA, which is exclusively maternally inherited in humans.
生物标志物研究表明,母亲患有晚发性阿尔茨海默病(LOAD)的成年子女存在葡萄糖代谢低下和淀粉样蛋白-β沉积增加的遗传倾向,但父亲患病则没有这种遗传倾向。其潜在的遗传机制尚不清楚。我们研究了认知正常(NL)个体中,是否存在携带母亲 LOAD 病史(MH)者的血小板线粒体细胞色素氧化酶活性(COX,电子传递链复合物 IV)低于携带父亲 LOAD 病史(PH)或无家族病史(NH)者。共纳入 36 名连续的 NL 个体(年龄 55±15 岁,范围 27-71 岁,56%为女性,CDR = 0,MMSE ≥28,28%为 APOE-4 携带者),包括 12 名 NH、12 名 PH 和 12 名 MH,采集血样以测量血小板线粒体 COX 活性。同时测量柠檬酸合酶活性(CS)作为参考。各组在临床和神经心理学指标上具有可比性。我们发现,在 CS 校正后,MH 组 COX 活性较 NH 组降低了 29%,较 PH 组降低了 30%(p≤0.006)。在控制年龄、性别、教育程度和 APOE 后,结果仍然显著。PH 组和 NH 组之间无差异。COX 测量值可将 MH 与其他两组区分开来,准确率≥75%,相对风险≥3(p≤0.005)。在 NL 中,只有那些携带 LOAD-父母的 MH 组与 PH 和 NH 组相比,其血小板线粒体 COX 活性降低。母亲 LOAD 病史与全身 COX 减少之间的关联提示通过线粒体 DNA 传递,而线粒体 DNA 在人类中是完全母系遗传的。